Quest Offers New Long-COVID Panels for Consumers
Quest Diagnostics introduced two new comprehensive tests for consumers that provide patients with information about long-COVID health issues.
Read MorePosted by Andy Lundin | Mar 27, 2023 | Covid 19 |
Quest Diagnostics introduced two new comprehensive tests for consumers that provide patients with information about long-COVID health issues.
Read MorePosted by Andy Lundin | Mar 24, 2023 | Dementias & Alzheimer’s |
Scientists were awarded approximately $1.5 million to develop a new POC testing kit that can detect biomarkers for Alzheimer’s disease.
Read MorePosted by Andy Lundin | Mar 21, 2023 | Covid 19 |
DiaSorin received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Simplexa COVID & Flu A/B Direct assay.
Read MorePosted by Chris Wolski | Mar 21, 2023 | Molecular Diagnostic Analyzers |
Pharyngitis testing and diagnosis can be improved by utilizing existing molecular testing capacity increased due to COVID.
Read MorePosted by Andy Lundin | Mar 20, 2023 | Emerging & Zoonotic Diseases |
Cue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read More